InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by MATSUI CONNIE, Director. Insider active across 1 companies, notably Halozyme Therapeutics, INC.. In total, 5 disclosures have been published. Total volume traded: €1.4m. The latest transaction was disclosed on 5 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
06,206 shares0
Restricted Stock Units
SEC:0001179110-22-002910:0·
€675,47219,452 shares@ €34.7250.0085% mcap100.0% of flow
Common Stock
SEC:0001179110-21-009910·
€675,47219,452 shares@ €34.7250.0085% mcap50.0% of flow
Common Stock
SEC:0001179110-21-009910:0·
5,230 shares
Restricted Stock Units
SEC:0001179110-21-004973·
05,230 shares0
Restricted Stock Units
SEC:0001179110-21-004973:0·
5 of 5 declarations
About MATSUI CONNIE
Connie Matsui is a Board Member at Halozyme Therapeutics, Inc., a biopharmaceutical company. As a board member, Connie contributes to the company's governance and the development of strategies aimed at enhancing its performance. Her experience in the biopharmaceutical sector is an asset to the board.
